Drug Shortage Report for APO-NAPRO-NA

Last updated on 2022-08-05 History
Report ID 162077
Drug Identification Number 00784354
Brand name APO-NAPRO-NA
Common or Proper name NAPROXEN-NA
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN SODIUM
Strength(s) 275MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BRL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-02
Estimated end date 2022-08-19
Actual end date
Shortage status Actual shortage
Updated date 2022-08-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-08-05 French Compare
v5 2022-08-05 English Compare
v4 2022-06-24 French Compare
v3 2022-06-24 English Compare
v2 2022-06-06 French Compare
v1 2022-06-06 English Compare

Showing 1 to 6 of 6